Market research
IUI1.F Intuitive Surgical, Inc
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 116B
- P/E ratio
- 43.37
- Analyst target
- 1021.8
- Dividend yield
- Not available
- Beta
- 1.46
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- ISIN
- US46120E6023
- Market cap
- 116B
- P/E ratio
- 43.37
- Analyst target
- 1021.8
- Dividend yield
- Not available
- Beta
- 1.46
About
About Intuitive Surgical, Inc
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the IUI1.F discussion.
5 years, 4 months ago
Intuitive Surgical, Inc is currently in a long term uptrend where the price is trading 21.8% above its 200 day moving average.
From a valuation standpoint, the stock is 98.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 20.7.
Intuitive Surgical, Inc's total revenue rose by 4.0% to $1B since the same quarter in the previous year.
Its net income has increased by 2.1% to $365M since the same quarter in the previous year.
Finally, its free cash flow grew by 37.7% to $566M since the same quarter in the previous year.
Based on the above factors, Intuitive Surgical, Inc gets an overall score of 5/5.